GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS: Gilteritinib (XOSPATA ®) in Turkey. (2023). Mediterranean Journal of Hematology and Infectious Diseases, 15(1), e2023031. https://doi.org/10.4084/MJHID.2023.031